Spartan Bioscience Submits Rapid, Portable COVID-19 Test to Health Canada For Approval

Share Article

After successful completion of their clinical study, Spartan has submitted its rapid COVID test for approval.

Spartan Cube

Spartan Cube

“Our team has worked incredibly hard to deliver an accurate, easy-to-use, on-site rapid COVID testing system,” said Roger Eacock, Chief Executive Officer of Spartan Bioscience.

Spartan Bioscience today announced it has officially re-submitted its rapid, accurate, and portable COVID-19 test for Health Canada review. This is the final step in Canada’s regulatory process. Once approved, Spartan will immediately begin shipping our made-in-Canada COVID-19 tests to our existing commercial and government partners.

“Our team has worked incredibly hard to deliver an accurate, easy-to-use, on-site rapid COVID testing system,” said Roger Eacock, Chief Executive Officer of Spartan Bioscience. “After conducting clinical trials, we are confident our efforts have paid off. We are grateful to our government and commercial partners across the country for supporting this made-in-Canada testing solution.”

Spartan’s application to Health Canada includes results from the required clinical studies, where Spartan’s rapid on-site test was compared to one of the most sensitive lab-based COVID-19 tests on the market today. The clinical studies were successfully completed in Canada and the U.S.

Slowing COVID-19 and re-opening the economy requires more testing, and Spartan is proud to be partnering with the federal and provincial governments in Canada to make their tests widely available to Canadians. Spartan’s COVID-19 Test is made by Canadians, for Canadians.

Spartan will continue to provide updates as the tests are approved and distributed across Canada.

About Spartan Bioscience
Founded in 2005, Spartan Bioscience is a Canadian biotechnology company and leader in portable molecular diagnostic testing. The Spartan Cube® brings complete sample-to-result DNA testing to fields such as precision medicine, environmental water testing, and infectious diseases. Spartan’s technology has been published in prestigious medical journals including The Lancet and The New England Journal of Medicine and is used by expert organizations such as the Centers for Disease Control & Prevention (CDC) and Mayo Clinic.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Molly Kett, Director of Communications
Spartan Bioscience Inc.
+1 877-228-7756 Ext: 711
Email >
@spartanbio
since: 11/2013
Follow >
Spartan Bioscience
Like >
Visit website